Clinical Trial

NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study

Study acronym: NAZA
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn about the comparisons of inflammatory markers between IBD and non-IBD (control) participants. The main question it aims to answer is: Are there differences in inflammatory markers between IBD and non-IBD (control) participants.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-24; most recent amendment 2026-07-06.
Trial Details
NCT Number NCT06956703
Lead Sponsor University of Nottingham
Collaborators: Nottingham University Hospitals NHS Trust
Conditions Gastro-Intestinal Disorder, Crohn Disease, Ulcerative Colitis, Inflammatory Bowel Diseases
Enrollment 240 participants
Start Date 2022-12-12
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-08